I'm wondering if we hit .80 before HIV data is published. I'm worried that it's going to not live up to expectations, although the action of insiders and the company recently gives me reassurance that they think it's good. If it doesn't live up to expectations, I think a lot of people are going to be turned off investing in INO if HIV data blah.